Literature DB >> 12687657

Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials.

L M Sullivan1, R B D'Agostino.   

Abstract

In clinical trials comparing two treatments, ordinal scales of three, four or five points are often used to assess severity, both prior to and after treatment. Analysis of covariance is an attractive technique, however, the data clearly violate the normality assumption and in the presence of small samples, and large sample theory may not apply. The robustness and power of various versions of parametric analysis of covariance applied to small samples of ordinal scaled data are investigated through computer simulation. Subjects are randomized to one of two competing treatments and the pre-treatment, or baseline, assessment is used as the covariate. We compare two parametric analysis of covariance tests that vary according to the treatment of the homogeneity of regressions slopes and the two independent samples t-test on difference scores. Under the null hypothesis of no difference in adjusted treatment means, we estimated actual significance levels by comparing observed test statistics to appropriate critical values from the F- and t-distributions for nominal significance levels of 0.10, 0.05, 0.02 and 0.01. We estimated power by similar comparisons under various alternative hypotheses. The model which assumes homogeneous slopes and the t-test on difference scores were robust in the presence of three, four and five point ordinal scales. The hierarchical approach which first tests for homogeneity of regression slopes and then fits separate slopes if there is significant non-homogeneity produced significance levels that exceeded the nominal levels especially when the sample sizes were small. The model which assumes homogeneous regression slopes produced the highest power among competing tests for all of the configurations investigated. The t-test on difference scores also produced good power in the presence of small samples. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12687657     DOI: 10.1002/sim.1433

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  10 in total

1.  Height gain after two-years-of-age is associated with better cognitive capacity, measured with Raven's coloured matrices at 15-years-of-age in Malawi.

Authors:  Tiina Teivaanmäki; Yin Bun Cheung; Anna Pulakka; Jussi Virkkala; Kenneth Maleta; Per Ashorn
Journal:  Matern Child Nutr       Date:  2016-06-29       Impact factor: 3.092

Review 2.  Parent-child agreement across child health-related quality of life instruments: a review of the literature.

Authors:  Penney Upton; Joanne Lawford; Christine Eiser
Journal:  Qual Life Res       Date:  2008-06-03       Impact factor: 4.147

3.  Combining risk communication strategies to simultaneously convey the risks of four diseases associated with physical inactivity to socio-demographically diverse populations.

Authors:  Eva Janssen; Robert A C Ruiter; Erika A Waters
Journal:  J Behav Med       Date:  2017-10-13

4.  The use of bootstrap methods for analysing Health-Related Quality of Life outcomes (particularly the SF-36).

Authors:  Stephen J Walters; Michael J Campbell
Journal:  Health Qual Life Outcomes       Date:  2004-12-09       Impact factor: 3.186

Review 5.  Practical statistics in pain research.

Authors:  Tae Kyun Kim
Journal:  Korean J Pain       Date:  2017-09-29

6.  Sample size estimation for randomised controlled trials with repeated assessment of patient-reported outcomes: what correlation between baseline and follow-up outcomes should we assume?

Authors:  Stephen J Walters; Richard M Jacques; Inês Bonacho Dos Anjos Henriques-Cadby; Jane Candlish; Nikki Totton; Mica Teo Shu Xian
Journal:  Trials       Date:  2019-09-13       Impact factor: 2.279

7.  Testing and Psychometric Validation of a Pediatric Instrument to Self-Assess Symptoms of the Common Cold.

Authors:  Rob Arbuckle; Patricia Halstead; Chris Marshall; Brenda Zimmerman; Kate Bolton; Antoine Regnault; Cathy Gelotte
Journal:  Patient       Date:  2020-11-11       Impact factor: 3.883

8.  INvolvement of breast CAncer patients during oncological consultations: a multicentre randomised controlled trial--the INCA study protocol.

Authors:  Claudia Goss; Alberto Ghilardi; Giuseppe Deledda; Chiara Buizza; Alessandro Bottacini; Lidia Del Piccolo; Michela Rimondini; Federica Chiodera; Maria Angela Mazzi; Mario Ballarin; Irene Bighelli; Maria Grazia Strepparava; Annamaria Molino; Elena Fiorio; Rolando Nortilli; Chiara Caliolo; Serena Zuliani; Alessandra Auriemma; Federica Maspero; Edda Lucia Simoncini; Fulvio Ragni; Richard Brown; Christa Zimmermann
Journal:  BMJ Open       Date:  2013-05-02       Impact factor: 2.692

9.  Sample size and power estimation for studies with health related quality of life outcomes: a comparison of four methods using the SF-36.

Authors:  Stephen J Walters
Journal:  Health Qual Life Outcomes       Date:  2004-05-25       Impact factor: 3.186

10.  Sense of Coherence and Health-Related Quality of Life in Patients with Multiple Sclerosis: The Role of Physical and Neurological Disability.

Authors:  Joanna Dymecka; Rafał Gerymski; Rafał Tataruch; Mariola Bidzan
Journal:  J Clin Med       Date:  2022-03-19       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.